- Curaleaf (TSX:CURA) is aligning itself with potential US federal legalization through an effort to redomicile from British Columbia to the state of Delaware
- Curaleaf is an international cannabis consumer products company active in Canada, the United States, Europe and Australasia
- The cannabis stock has added 63.21 per cent year-over-year
Curaleaf Holdings (TSX:CURA), one of the world’s top cannabis companies, is aligning itself with potential US federal legalization through an effort to redomicile from British Columbia to the state of Delaware.
The move, which will require 66.6 per cent shareholder approval, follows US president Trump’s support for rescheduling cannabis as a less dangerous drug, first voiced in December, which would facilitate research on the plant and make it easier for businesses to create value from it.
According to Thursday’s news release, Curaleaf views Delaware’s favorable corporate environment as a means to expediting its objectives and optimizing its organizational and regulatory structure, ultimately making it a more efficient business.
While the news release goes on to state that the arrangement “is not expected to cause any material change in the company’s business or operations,” the shift in optics is clear, granting Curaleaf a clearer path to expanding its already considerable US operations, including a presence in 17 states and an addressable US population of about 257 million, according to data from the company’s investor presentation dated August 2025.
Leadership intends to hold the required shareholder vote on or about February 23, 2026.
Management commentary
“We believe the continuance to Delaware will reflect and better align with our business, operational focus and strategic objectives, while also providing other expected and potential benefits,” Boris Jordan, chairman and chief executive officer of Curaleaf, said in a statement.
About Curaleaf Holdings
Curaleaf is an international cannabis consumer products company active in Canada, the United States, Europe and Australasia. Its brand portfolio includes Curaleaf, Select, Grassroots, Find, Anthem and The Hemp Company.
Curaleaf stock (TSX:CURA) is up by 0.87 per cent on the news trading at C$3.46 as of 10:39 am ET. The stock has added 63.21 per cent year-over-year.
Join the discussion: Find out what investors are saying about this cannabis stock on the Curaleaf Holdings Inc. Bullboard and make sure to explore the rest of Stockhouse’s stock forums and message boards.
Stockhouse does not provide investment advice or recommendations. All investment decisions should be made based on your own research and consultation with a registered investment professional. The issuer is solely responsible for the accuracy of the information contained herein.
For full disclaimer information, please click here.
